• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达托霉素对西班牙医疗中心血流感染分离出的葡萄球菌的活性。

Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.

作者信息

Picazo Juan J, Betriu Carmen, Culebras Esther, Rodríguez-Avial Iciar, Gómez María, López Fátima

机构信息

Servicio de Microbiología Clínica, Hospital Clínico San Carlos, 28040 Madrid, Spain.

出版信息

Diagn Microbiol Infect Dis. 2009 Aug;64(4):448-51. doi: 10.1016/j.diagmicrobio.2009.03.020.

DOI:10.1016/j.diagmicrobio.2009.03.020
PMID:19631100
Abstract

We used the broth microdilution method to determine the MICs of daptomycin and 13 comparator agents against 319 methicillin-susceptible Staphylococcus aureus isolates, 201 methicillin-resistant S. aureus (MRSA) isolates, and 183 coagulase-negative staphylococci (CoNS). Isolates were consecutively collected from bloodstream infections in 39 Spanish medical centers during a 3-month period (March through May 2008). Among MRSA, 1 isolate with intermediate susceptibility to vancomycin and 6 isolates resistant to linezolid were found. Nonsusceptibility to teicoplanin was detected in 3.9% of CoNS. Daptomycin was highly active against the staphylococcal blood isolates tested-all were inhibited at the daptomycin susceptibility breakpoint of < or = 1 microg/mL. Daptomycin retained its activity against the isolates that were resistant to teicoplanin or linezolid, or that had reduced susceptibility to vancomycin. These data suggest that daptomycin could be useful for the treatment of bloodstream infections caused by staphylococci.

摘要

我们采用肉汤微量稀释法测定了达托霉素及13种对照药物对319株甲氧西林敏感金黄色葡萄球菌、201株耐甲氧西林金黄色葡萄球菌(MRSA)及183株凝固酶阴性葡萄球菌(CoNS)的最低抑菌浓度(MIC)。在3个月期间(2008年3月至5月),从西班牙39个医疗中心的血流感染患者中连续收集分离菌株。在MRSA中,发现1株对万古霉素中度敏感,6株对利奈唑胺耐药。在3.9%的CoNS中检测到对替考拉宁不敏感。达托霉素对所检测的葡萄球菌血流分离株具有高度活性——所有菌株在达托霉素敏感折点≤1μg/mL时均被抑制。达托霉素对耐替考拉宁或利奈唑胺、或对万古霉素敏感性降低的分离株仍保持活性。这些数据表明,达托霉素可用于治疗由葡萄球菌引起的血流感染。

相似文献

1
Activity of daptomycin against staphylococci collected from bloodstream infections in Spanish medical centers.达托霉素对西班牙医疗中心血流感染分离出的葡萄球菌的活性。
Diagn Microbiol Infect Dis. 2009 Aug;64(4):448-51. doi: 10.1016/j.diagmicrobio.2009.03.020.
2
[Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].达托霉素对耐甲氧西林金黄色葡萄球菌和凝固酶阴性葡萄球菌临床分离株的比较活性
Enferm Infecc Microbiol Clin. 2010 Jan;28(1):13-6. doi: 10.1016/j.eimc.2008.09.012. Epub 2009 May 5.
3
Comparative activities of daptomycin and several agents against staphylococcal blood isolates. Glycopeptide tolerance.达托霉素与几种药物对葡萄球菌血分离株的比较活性。糖肽类耐药性。
Diagn Microbiol Infect Dis. 2011 Jul;70(3):373-9. doi: 10.1016/j.diagmicrobio.2011.02.009.
4
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).针对2005年在欧洲医疗中心分离出的耐甲氧西林葡萄球菌和耐万古霉素肠球菌测试达托霉素的抗菌活性。
BMC Infect Dis. 2007 Apr 18;7:29. doi: 10.1186/1471-2334-7-29.
5
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.万古霉素中介和耐万古霉素金黄色葡萄球菌(hVISA)在 9 家美国医院血流感染中的发生情况。
J Antimicrob Chemother. 2009 Nov;64(5):1024-8. doi: 10.1093/jac/dkp319. Epub 2009 Sep 10.
6
In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.头孢比普、达托霉素、利奈唑胺和万古霉素对与心内膜炎及骨和关节感染相关的耐甲氧西林葡萄球菌的体外活性。
Diagn Microbiol Infect Dis. 2007 Jul;58(3):363-5. doi: 10.1016/j.diagmicrobio.2007.02.010. Epub 2007 Apr 20.
7
Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.2001年至2005年期间,非万古霉素中介金黄色葡萄球菌(VISA)、对万古霉素敏感的临床耐甲氧西林金黄色葡萄球菌(MRSA)血源分离株中万古霉素最低抑菌浓度(MIC)的缓慢上升。
J Antimicrob Chemother. 2007 Oct;60(4):788-94. doi: 10.1093/jac/dkm258. Epub 2007 Jul 10.
8
In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.达托霉素和替加环素对骨髓移植受者凝固酶阴性葡萄球菌血培养分离株的体外活性
Eur J Haematol. 2007 Nov;79(5):405-9. doi: 10.1111/j.1600-0609.2007.00945.x. Epub 2007 Aug 20.
9
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients.达托霉素及选定对照药物对血液透析患者血流中分离出的金黄色葡萄球菌菌株的抗菌活性。
Int J Infect Dis. 2009 Mar;13(2):291-5. doi: 10.1016/j.ijid.2008.07.006. Epub 2008 Oct 19.
10
[Methicillin-resistant Staphylococcus aureus: changes in the susceptibility pattern to daptomycin during a 10-year period (2001-2010)].[耐甲氧西林金黄色葡萄球菌:2001年至2010年期间对达托霉素敏感性模式的变化]
Rev Esp Quimioter. 2011 Jun;24(2):107-11.

引用本文的文献

1
The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.全球达托霉素、替加环素、奎奴普丁/达福普汀和利奈唑胺耐药金黄色葡萄球菌和凝固酶阴性葡萄球菌菌株的流行情况:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2020 Apr 22;9(1):56. doi: 10.1186/s13756-020-00714-9.